Modeling psychiatric disorders with patient-derived iPSCs

Zhexing Wen1, Kimberly M Christian1, Hongjun Song2

  • 1Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Insights

Induced pluripotent stem cells (iPSCs) offer a new way to study complex psychiatric disorders. This research reviews how iPSCs can model disease and aid in developing more predictable, targeted therapeutics.

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Genetics

Background:

  • Psychiatric disorders are complex with challenging genetics and variable symptoms.
  • Current treatments lack specificity and can disrupt neural systems.
  • There is a need for rational therapeutics with higher predictability.

Purpose of the Study:

  • To review the use of induced pluripotent stem cells (iPSCs) for modeling neuropsychiatric disorders.
  • To discuss the potential of iPSCs in developing novel therapeutic strategies.

Main Methods:

  • Review of recent progress in utilizing human iPSCs.
  • Analysis of challenges in iPSC-based disease modeling and drug discovery.

Main Results:

  • iPSCs can recapitulate normal and pathological human tissue development.
  • iPSCs provide a platform for understanding disease mechanisms.
  • iPSCs facilitate drug discovery with higher predictability in humans.

Conclusions:

  • Human iPSCs represent a powerful tool for studying neuropsychiatric disorders.
  • iPSC technology offers promising avenues for developing targeted and effective therapeutics.

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

4.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K